Crossmark

Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”

Crossref DOI link: https://doi.org/10.1186/s41983-020-00260-6

Published Online: 2021-01-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mansoor, Salman http://orcid.org/0000-0001-5515-5972
Mullane, Gerard

Adenan, Mohammad Hijaz

Kelly, Siobhan

Water, Aine

McPartland, Grainne

Murphy, Kevin
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 9 October 2020

Accepted: 11 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: Ethical approval from ERB at Sligo University Hospital is not applicable in case reports, and written consent was obtained.

: Written and informed consent is obtained for this case report from the patient.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below